Skip to main content

Avalyn Pharma Inc.

AVLN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001540171

No open-market purchases or sales by Avalyn Pharma Inc. insiders were filed in the last 90 days; 93 institutions reported holding it in 13F filings for Q2 2026, worth $1.46B in total; Soros Fund Management is the only superinvestor holding it.

Politicians who traded AVLN

No member of Congress has reported a trade in Avalyn Pharma Inc. shares or options since 2020.

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report. Profiles, committees and photos: the unitedstates project (public domain). District maps: U.S. Census Bureau.